-transparent.png){kind=logo}
Cyclosporin toxicity may produce a wide range of neurological disorders. We report three patients whose neurological problems developed while taking cyclosporin following cardiac transplantation, but resolved rapidly when the drug was discontinued. In two cases, MRI revealed abnormalities which disappeared with clinical recovery. Blood cyclosporin concentrations were not markedly increased, and it is possible that the neurotoxic effects of cyclosporin are mediated by metabolites, through an effect on the blood-brain barrier.
Related Publications
R J Lane, and
S W Roche, and
A A Leung, and
A Greco, and
L S Lange
June 1989,
Journal of neurology, neurosurgery, and psychiatry,
R J Lane, and
S W Roche, and
A A Leung, and
A Greco, and
L S Lange
January 1996,
Infection,
R J Lane, and
S W Roche, and
A A Leung, and
A Greco, and
L S Lange
December 1997,
Circulation,
R J Lane, and
S W Roche, and
A A Leung, and
A Greco, and
L S Lange
August 1999,
Pediatric transplantation,
R J Lane, and
S W Roche, and
A A Leung, and
A Greco, and
L S Lange
June 1997,
Clinical pharmacokinetics,
R J Lane, and
S W Roche, and
A A Leung, and
A Greco, and
L S Lange
March 2009,
Transplantation,
R J Lane, and
S W Roche, and
A A Leung, and
A Greco, and
L S Lange
October 1981,
Lancet (London, England),
R J Lane, and
S W Roche, and
A A Leung, and
A Greco, and
L S Lange
January 2002,
Clinical pharmacokinetics,
R J Lane, and
S W Roche, and
A A Leung, and
A Greco, and
L S Lange
December 2002,
Transplantation proceedings,
R J Lane, and
S W Roche, and
A A Leung, and
A Greco, and
L S Lange
January 1999,
Oral diseases,
